rs1936439
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001142800.2(EYS):c.1300-3C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.678 in 1,606,356 control chromosomes in the GnomAD database, including 370,343 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001142800.2 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000503581.6 | |||
EYS | NM_001142801.2 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ||||
EYS | NM_001292009.2 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ||||
EYS | NM_198283.2 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 5 | NM_001142800.2 | A2 | |||
EYS | ENST00000342421.9 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | |||||
EYS | ENST00000370621.7 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | P2 | ||||
EYS | ENST00000393380.6 | c.1300-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.675 AC: 102361AN: 151758Hom.: 34610 Cov.: 31
GnomAD3 exomes AF: 0.671 AC: 168175AN: 250504Hom.: 56712 AF XY: 0.675 AC XY: 91353AN XY: 135386
GnomAD4 exome AF: 0.678 AC: 986330AN: 1454480Hom.: 335720 Cov.: 33 AF XY: 0.680 AC XY: 492000AN XY: 723924
GnomAD4 genome AF: 0.674 AC: 102414AN: 151876Hom.: 34623 Cov.: 31 AF XY: 0.672 AC XY: 49883AN XY: 74210
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2011 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 17, 2023 | - - |
Retinitis pigmentosa 25 Benign:3
Benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | May 31, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 01, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Retinitis pigmentosa Benign:2
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at